Aspr-21-00574 -- base period fund to mbio diagnostics to develop their lightdeck sars-COV ultra-rapid antigen test to achieve EUA and 510K clearance
Ended Purchase Order Awarded Last action
- Contract number
- 75A50121P00026
- Awardee
-
Mbio Diagnostics Inc. UEI HMBEH3F1D7T3
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $5,654,478
Award facts
- Opportunity
-
- EUA and 510(k) clearance of SARS-CoV-2 Antigen Diagnostic Test Award Notice · Posted Feb 3, 2021
- Contract value 100% obligated
- $5,654,478.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boulder, CO 80303, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $5,654,478 |
About this award
Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, has been awarded a firm fixed-price purchase order valued at $5,654,478 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The base period of performance for this contract is from February 3, 2021 through February 2, 2022. Under the contract, Lightdeck Diagnostics will develop its Lightdeck SARS-CoV Ultra-Rapid Antigen Test to achieve Emergency Use Authorization from the U.S. Food and Drug Administration and 510(k) clearance. The work will be performed in Boulder, Colorado. This award provides funding to Lightdeck Diagnostics under the ASPR's initiative to accelerate the development, manufacturing, and distribution of critical medical countermeasures, such as antigen tests, in support of the U.S. Government's response to the Coronavirus Disease 2019 pandemic.
Quick answers
Who was awarded contract 75A50121P00026?
75A50121P00026 was awarded to Mbio Diagnostics Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on February 3, 2021.
How much is contract 75A50121P00026 worth?
The government has obligated $5,654,478 on 75A50121P00026.
Was contract 75A50121P00026 competed?
The extent of competition for 75A50121P00026 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award